Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel
Tóm tắt
Từ khóa
Tài liệu tham khảo
Goodman Z, Becker RJ, Pockros P, Afdhal N (2007) Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology 45(4):886–894. doi: 10.1002/hep.21595
Shiffman ML, Stravitz RT, Contos MJ, et al. (2004) Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 10(10):1248–1255. doi: 10.1002/lt.20232
Lee YA, Wallace MC, Friedman SL (2015) Pathobiology of liver fibrosis: a translational success story. Gut 64(5):830–841. doi: 10.1136/gutjnl-2014-306842
Schuppan D (1990) Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 10(1):1–10. doi: 10.1055/s-2008-1040452
Pinzani M, Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36(4):231–242. doi: 10.1016/j.dld.2004.01.003
Pinzani M, Rombouts K, Colagrande S (2005) Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 42(Suppl 1):S22–36. doi: 10.1016/j.jhep.2004.12.008
Ratziu V, Charlotte F, Heurtier A, et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128(7):1898–1906. doi: 10.1053/j.gastro.2005.03.084
Regev A, Berho M, Jeffers LJ, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97(10):2614–2618. doi: 10.1111/j.1572-0241.2002.06038.x
Chen J, Yin M, Talwalkar JA, et al. (2017) Diagnostic performance of MR elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity. Radiology 283(2):418–428. doi: 10.1148/radiol.2016160685
Dai DF, Swanson PE, Krieger EV, et al. (2014) Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol 27(12):1552–1558. doi: 10.1038/modpathol.2014.79
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94(9):2467–2474. doi: 10.1111/j.1572-0241.1999.01377.x
Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP (2006) An appraisal of the histopathological assessment of liver fibrosis. Gut 55(4):569–578. doi: 10.1136/gut.2005.084475
Lazzarini AL, Levine RA, Ploutz-Snyder RJ, Sanderson SO (2005) Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int 25(6):1142–1149. doi: 10.1111/j.1478-3231.2005.01155.x
Knodell RG, Ishak KG, Black WC, et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1(5):431–435
Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24(2):289–293. doi: 10.1002/hep.510240201
Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19(12):1409–1417
Elphick DA, Dube AK, McFarlane E, Jones J, Gleeson D (2007) Spectrum of liver histology in presumed decompensated alcoholic liver disease. Am J Gastroenterol 102(4):780–788. doi: 10.1111/j.1572-0241.2006.01034.x
Kakuda Y, Harada K, Sawada-Kitamura S, et al. (2013) Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems. Hum Pathol 44(6):1107–1117. doi: 10.1016/j.humpath.2012.09.017
Portmann B, Zen Y (2012) Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation. Histopathology 60(2):236–248. doi: 10.1111/j.1365-2559.2011.03853.x
Kim MY, Cho MY, Baik SK, et al. (2011) Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 55(5):1004–1009. doi: 10.1016/j.jhep.2011.02.012
Rastogi A, Maiwall R, Bihari C, et al. (2013) Cirrhosis histology and Laennec staging system correlate with high portal pressure. Histopathology 62(5):731–741. doi: 10.1111/his.12070
Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G (2006) Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol 44(1):111–117. doi: 10.1016/j.jhep.2005.07.036
Tsochatzis E, Bruno S, Isgro G, et al. (2014) Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. J Hepatol 60(5):948–954. doi: 10.1016/j.jhep.2013.12.023
Kumar M, Sakhuja P, Kumar A, et al. (2008) Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 27(9):771–779. doi: 10.1111/j.1365-2036.2008.03653.x
Guido M (2011) Chronic hepatitis: grading and staging. In: Saxena R (ed). Practical Hepatic Pathology: A Diagnostic Approach. St. Louis: WB Sanders, pp 201–213. doi: 10.1016/B978-0-443-06803-4.00016-2
Goodman ZD, Stoddard AM, Bonkovsky HL, et al. (2009) Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial. Hepatology 50(6):1738–1749. doi: 10.1002/hep.23211
Chou R, Wasson N (2013) Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med 158(11):807–820. doi: 10.7326/0003-4819-158-11-201306040-00005
Parkes J, Guha IN, Roderick P, Rosenberg W (2006) Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 44(3):462–474. doi: 10.1016/j.jhep.2005.10.019
Udell JA, Wang CS, Tinmouth J, et al. (2012) Does this patient with liver disease have cirrhosis? Jama 307(8):832–842. doi: 10.1001/jama.2012.186
Tan KC (2008) Enlargement of the hilar periportal space. Radiology 248(2):699–700. doi: 10.1148/radiol.2482060463
Ito K, Mitchell DG, Gabata T (2000) Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging 11(2):136–140
Awaya H, Mitchell DG, Kamishima T, et al. (2002) Cirrhosis: modified caudate-right lobe ratio. Radiology 224(3):769–774. doi: 10.1148/radiol.2243011495
Di Lelio A, Cestari C, Lomazzi A, Beretta L (1989) Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 172(2):389–392
Giorgio A, Amoroso P, Lettieri G, et al. (1986) Cirrhosis: value of caudate to right lobe ratio in diagnosis with US. Radiology 161(2):443–445. doi: 10.1148/radiology.161.2.3532188
Ito K, Mitchell DG, Gabata T, Hussain SM (1999) Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 211(3):723–726. doi: 10.1148/radiology.211.3.r99ma31723
Ito K, Mitchell DG, Kim MJ, et al. (2003) Right posterior hepatic notch sign: a simple diagnostic MR finding of cirrhosis. J Magn Reson Imaging 18(5):561–566. doi: 10.1002/jmri.10387
Lafortune M, Matricardi L, Denys A, et al. (1998) Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US. Radiology 206(1):157–160. doi: 10.1148/radiology.206.1.9423666
Simonovsky V (1999) The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. Br J Radiol 72(853):29–34
Tan KC (2008) The right posterior hepatic notch sign. Radiology 248(1):317–318. doi: 10.1148/radiol.2481051024
Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME (1986) Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr 10(1):47–50
Yu JS, Shim JH, Chung JJ, Kim JH, Kim KW (2010) Double contrast-enhanced MRI of viral hepatitis-induced cirrhosis: correlation of gross morphological signs with hepatic fibrosis. Br J Radiol 83(987):212–217. doi: 10.1259/bjr/70974553
Zhang Y, Zhang XM, Prowda JC, et al. (2009) Changes in hepatic venous morphology with cirrhosis on MRI. J Magn Reson Imaging 29(5):1085–1092. doi: 10.1002/jmri.21718
Rustogi R, Horowitz J, Harmath C, et al. (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35(6):1356–1364. doi: 10.1002/jmri.23585
Venkatesh SK, Yin M, Takahashi N, et al. (2015) Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography. Abdom Imaging 40(4):766–775. doi: 10.1007/s00261-015-0347-6
Aube C, Oberti F, Korali N, et al. (1999) Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 30(3):472–478
Allan R, Thoirs K, Phillips M (2010) Accuracy of ultrasound to identify chronic liver disease. World J Gastroenterol 16(28):3510–3520
Colli A, Colucci A, Paggi S, et al. (2005) Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C. World J Gastroenterol 11(46):7318–7322
Bonekamp S, Kamel I, Solga S, Clark J (2009) Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 50(1):17–35. doi: 10.1016/j.jhep.2008.10.016
Tchelepi H, Ralls PW, Radin R, Grant E (2002) Sonography of diffuse liver disease. J Ultrasound Med 21(9):1023–1032 (quiz 1033–1024)
Hultcrantz R, Gabrielsson N (1993) Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 233(1):7–12
Mathiesen UL, Franzen LE, Aselius H, et al. (2002) Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 34(7):516–522
Haktanir A, Cihan BS, Celenk C, Cihan S (2005) Value of Doppler sonography in assessing the progression of chronic viral hepatitis and in the diagnosis and grading of cirrhosis. J Ultrasound Med 24(3):311–321
Kawanaka H, Kinjo N, Anegawa G, et al. (2008) Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implications. J Gastroenterol Hepatol 23(7 Pt 2):e129–e136. doi: 10.1111/j.1440-1746.2007.05155.x
Oguzkurt L, Yildirim T, Torun D, et al. (2005) Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 54(2):253–257. doi: 10.1016/j.ejrad.2004.05.011
Bernatik T, Strobel D, Hahn EG, Becker D (2002) Doppler measurements: a surrogate marker of liver fibrosis? Eur J Gastroenterol Hepatol 14(4):383–387
Tang A, Cloutier G, Szeverenyi NM, Sirlin CB (2015) Ultrasound elastography and MR elastography for assessing liver fibrosis: part 1, principles and techniques. Am J Roentgenol 205(1):22–32. doi: 10.2214/AJR.15.14552
Bota S, Herkner H, Sporea I, et al. (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 33(8):1138–1147. doi: 10.1111/liv.12240
Friedrich-Rust M, Ong MF, Martens S, et al. (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134(4):960–974. doi: 10.1053/j.gastro.2008.01.034
Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM (2007) Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 5(10):1214–1220. doi: 10.1016/j.cgh.2007.07.020
Tsochatzis EA, Gurusamy KS, Ntaoula S, et al. (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 54(4):650–659. doi: 10.1016/j.jhep.2010.07.033
Tang A, Cloutier G, Szeverenyi NM, Sirlin CB (2015) Ultrasound elastography and MR elastography for assessing liver fibrosis: part 2, diagnostic performance, confounders, and future directions. Am J Roentgenol 205(1):33–40. doi: 10.2214/AJR.15.14553
Ferraioli G, Tinelli C, Dal Bello B, et al. (2013) Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol 19(1):49–56. doi: 10.3748/wjg.v19.i1.49
Kim SU, Han KH, Ahn SH (2010) Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol 16(41):5173–5180
Reiberger T, Ferlitsch A, Payer BA, et al. (2012) Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience. Wien Klin Wochenschr 124(11–12):395–402. doi: 10.1007/s00508-012-0190-5
Degos F, Perez P, Roche B, et al. (2010) Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 53(6):1013–1021. doi: 10.1016/j.jhep.2010.05.035
Myers RP, Pomier-Layrargues G, Kirsch R, et al. (2012) Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 56(3):564–570. doi: 10.1016/j.jhep.2011.10.007
Friedrich-Rust M, Hadji-Hosseini H, Kriener S, et al. (2010) Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol 20(10):2390–2396. doi: 10.1007/s00330-010-1820-9
Naveau S, Lamouri K, Pourcher G, et al. (2014) The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg 24(10):1693–1701. doi: 10.1007/s11695-014-1235-9
Yoneda M, Suzuki K, Kato S, et al. (2010) Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 256(2):640–647. doi: 10.1148/radiol.10091662
Palmeri ML, Wang MH, Rouze NC, et al. (2011) Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 55(3):666–672. doi: 10.1016/j.jhep.2010.12.019
Ochi H, Hirooka M, Koizumi Y, et al. (2012) Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology 56(4):1271–1278. doi: 10.1002/hep.25756
Friedrich-Rust M, Romen D, Vermehren J, et al. (2012) Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 81(3):e325–e331. doi: 10.1016/j.ejrad.2011.10.029
Guzman-Aroca F, Frutos-Bernal MD, Bas A, et al. (2012) Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. Eur Radiol 22(11):2525–2532. doi: 10.1007/s00330-012-2505-3
Sirli R, Bota S, Sporea I, et al. (2013) Liver stiffness measurements by means of supersonic shear imaging in patients without known liver pathology. Ultrasound Med Biol 39(8):1362–1367. doi: 10.1016/j.ultrasmedbio.2013.03.021
Sporea I, Bota S, Gradinaru-Tascau O, et al. (2014) Which are the cut-off values of 2D-shear wave elastography (2D-SWE) liver stiffness measurements predicting different stages of liver fibrosis, considering transient elastography (TE) as the reference method? Eur J Radiol 83(3):e118–e122. doi: 10.1016/j.ejrad.2013.12.011
Muller M, Gennisson JL, Deffieux T, Tanter M, Fink M (2009) Quantitative viscoelasticity mapping of human liver using supersonic shear imaging: preliminary in vivo feasibility study. Ultrasound Med Biol 35(2):219–229. doi: 10.1016/j.ultrasmedbio.2008.08.018
Gerber L, Kasper D, Fitting D, et al. (2015) Assessment of liver fibrosis with 2-D shear wave elastography in comparison to transient elastography and acoustic radiation force impulse imaging in patients with chronic liver disease. Ultrasound Med Biol 41(9):2350–2359. doi: 10.1016/j.ultrasmedbio.2015.04.014
Samir AE, Dhyani M, Vij A, et al. (2015) Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology 274(3):888–896. doi: 10.1148/radiol.14140839
Sporea I, Sirli RL, Deleanu A, et al. (2011) Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med 32(Suppl 1):S46–S52. doi: 10.1055/s-0029-1245360
Goertz RS, Zopf Y, Jugl V, et al. (2010) Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis. Ultraschall Med 31(2):151–155. doi: 10.1055/s-0029-1245244
Karlas T, Pfrepper C, Troeltzsch M, Wiegand J, Keim V (2010) Acoustic radiation force impulse liver stiffness measurement: interlobe differences demand standardized examination procedures. Eur J Gastroenterol Hepatol 22(11):1387. doi: 10.1097/MEG.0b013e32833caf8e
Mederacke I, Wursthorn K, Kirschner J, et al. (2009) Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 29(10):1500–1506. doi: 10.1111/j.1478-3231.2009.02100.x
Popescu A, Bota S, Sporea I, et al. (2013) The influence of food intake on liver stiffness values assessed by acoustic radiation force impulse elastography-preliminary results. Ultrasound Med Biol 39(4):579–584. doi: 10.1016/j.ultrasmedbio.2012.11.013
Arena U, Vizzutti F, Corti G, et al. (2008) Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47(2):380–384. doi: 10.1002/hep.22007
Millonig G, Reimann FM, Friedrich S, et al. (2008) Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48(5):1718–1723. doi: 10.1002/hep.22577
Millonig G, Friedrich S, Adolf S, et al. (2010) Liver stiffness is directly influenced by central venous pressure. J Hepatol 52(2):206–210. doi: 10.1016/j.jhep.2009.11.018
Venkatesh SK, Ehman RL (2015) Magnetic resonance elastography of abdomen. Abdom Imaging 40(4):745–759. doi: 10.1007/s00261-014-0315-6
Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37(3):544–555. doi: 10.1002/jmri.23731
Singh S, Venkatesh SK, Wang Z, et al. (2015) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13(3):440–451 e446. doi: 10.1016/j.cgh.2014.09.046
Guo Y, Parthasarathy S, Goyal P, et al. (2014) Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging . doi: 10.1007/s00261-014-0137-6
Godfrey EM, Patterson AJ, Priest AN, et al. (2012) A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 22(12):2790–2797. doi: 10.1007/s00330-012-2527-x
Hines CD, Bley TA, Lindstrom MJ, Reeder SB (2010) Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging 31(3):725–731. doi: 10.1002/jmri.22066
Lee DH, Lee JM, Han JK, Choi BI (2013) MR elastography of healthy liver parenchyma: normal value and reliability of the liver stiffness value measurement. J Magn Reson Imaging 38(5):1215–1223. doi: 10.1002/jmri.23958
Venkatesh SK, Wang G, Teo LL, Ang BW (2014) Magnetic resonance elastography of liver in healthy Asians: normal liver stiffness quantification and reproducibility assessment. J Magn Reson Imaging 39(1):1–8. doi: 10.1002/jmri.24084
Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56(1):239–247. doi: 10.1002/hep.25610
Castera L, Foucher J, Bernard PH, et al. (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51(3):828–835. doi: 10.1002/hep.23425
Bota S, Sporea I, Sirli R, et al. (2014) Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of Acoustic Radiation Force Impulse (ARFI) elastography—analysis of a cohort of 1,031 subjects. Eur J Radiol 83(2):268–272. doi: 10.1016/j.ejrad.2013.11.019
Huwart L, Sempoux C, Vicaut E, et al. (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135(1):32–40. doi: 10.1053/j.gastro.2008.03.076
Ichikawa S, Motosugi U, Ichikawa T, et al. (2012) Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. MRMS 11(4):291–297
Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL (2013) Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 268(2):411–419. doi: 10.1148/radiol.13121193
Venkatesh SK, Wang G, Lim SG, Wee A (2014) Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol 24(1):70–78. doi: 10.1007/s00330-013-2978-8
Yin M, Talwalkar JA, Glaser KJ, et al. (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5(10):1207–1213.e1202. doi: 10.1016/j.cgh.2007.06.012
Wagner M, Corcuera-Solano I, Lo G, et al. (2017) Technical failure of MR elastography examinations of the liver: experience from a large single-center study. Radiology . doi: 10.1148/radiol.2016160863
Wagner M, Besa C, Bou Ayache J, et al. (2016) Magnetic resonance elastography of the liver: qualitative and quantitative comparison of gradient echo and spin echo echoplanar imaging sequences. Invest Radiol 51(9):575–581. doi: 10.1097/RLI.0000000000000269
Yin M, Talwalkar JA, Glaser KJ, et al. (2011) Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease. Am J Roentgenol 197(1):64–70. doi: 10.2214/AJR.10.5989
Jajamovich GH, Dyvorne H, Donnerhack C, Taouli B (2014) Quantitative liver MRI combining phase contrast imaging, elastography, and DWI: assessment of reproducibility and postprandial effect at 3.0 T. PLoS ONE 9(5):e97355. doi: 10.1371/journal.pone.0097355
Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254(1):47–66. doi: 10.1148/radiol.09090021
Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging—pilot study. Radiology 249(3):891–899. doi: 10.1148/radiol.2493080080
Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210(3):617–623. doi: 10.1148/radiology.210.3.r99fe17617
Annet L, Peeters F, Abarca-Quinones J, et al. (2007) Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 25(1):122–128. doi: 10.1002/jmri.20771
Taouli B, Tolia AJ, Losada M, et al. (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. Am J Roentgenol 189(4):799–806. doi: 10.2214/AJR.07.2086
Girometti R, Furlan A, Bazzocchi M, et al. (2007) Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112(3):394–408. doi: 10.1007/s11547-007-0149-1
Dyvorne HA, Jajamovich GH, Bane O, et al. (2016) Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection. Liver Int 36(5):659–666. doi: 10.1111/liv.13058
Wang Y, Ganger DR, Levitsky J, et al. (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. Am J Roentgenol 196(3):553–561. doi: 10.2214/AJR.10.4580
Chandarana H, Do RK, Mussi TC, et al. (2012) The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis. AJR Am J Roentgenol 199(4):803–808. doi: 10.2214/ajr.11.7541
Dyvorne HA, Galea N, Nevers T, et al. (2013) Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters—a pilot study. Radiology 266(3):920–929. doi: 10.1148/radiol.12120686
Patel J, Sigmund EE, Rusinek H, et al. (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31(3):589–600. doi: 10.1002/jmri.22081
Zhang B, Liang L, Dong Y, et al. (2016) Intravoxel incoherent motion MR imaging for staging of hepatic fibrosis. PLoS ONE 11(1):e0147789. doi: 10.1371/journal.pone.0147789
Chung SR, Lee SS, Kim N, et al. (2015) Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study. Acta Radiol 56(12):1428–1436. doi: 10.1177/0284185114559763
Ichikawa S, Motosugi U, Morisaka H, et al. (2015) MRI-based staging of hepatic fibrosis: comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging 42(1):204–210. doi: 10.1002/jmri.24760
Parente DB, Paiva FF, Oliveira Neto JA, et al. (2015) Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients. PLoS ONE 10(5):e0125653. doi: 10.1371/journal.pone.0125653
Wu CH, Ho MC, Jeng YM, et al. (2015) Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. Eur Radiol 25(12):3552–3559. doi: 10.1007/s00330-015-3774-4
Jhaveri K, Cleary S, Audet P, et al. (2015) Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid). Am J Roentgenol 204(3):498–509. doi: 10.2214/ajr.13.12399
Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. Am J Roentgenol 195(1):13–28. doi: 10.2214/ajr.10.4392
Tsuda N, Okada M, Murakami T (2010) New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 73(1):137–142. doi: 10.1016/j.ejrad.2008.09.036
Motosugi U, Ichikawa T, Oguri M, et al. (2011) Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging 29(8):1047–1052. doi: 10.1016/j.mri.2011.05.007
Watanabe H, Kanematsu M, Goshima S, et al. (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging—preliminary observations. Radiology 259(1):142–150. doi: 10.1148/radiol.10100621
Hope TA, Doherty A, Fu Y, et al. (2012) Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis. Radiology 264(2):423–427. doi: 10.1148/radiol.12112453
Goshima S, Kanematsu M, Watanabe H, et al. (2012) Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio. J Magn Reson Imaging 36(5):1148–1153. doi: 10.1002/jmri.23758
Ding Y, Rao S, Yang L, Chen C, Zeng M (2016) Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis. Radiol Med 121(11):821–827. doi: 10.1007/s11547-016-0669-7
Ding Y, Rao SX, Zhu T, et al. (2015) Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging. Clin Radiol 70(10):1096–1103. doi: 10.1016/j.crad.2015.04.014
Park HS, Kim YJ, Yu MH, et al. (2014) Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging. World J Gastroenterol 20(46):17558–17567. doi: 10.3748/wjg.v20.i46.17558
Kim H, Park SH, Kim EK, et al. (2014) Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS ONE 9(12):e114224. doi: 10.1371/journal.pone.0114224
Okada M, Murakami T, Yada N, et al. (2015) Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver. J Magn Reson Imaging 41(2):329–338. doi: 10.1002/jmri.24529
Choi YR, Lee JM, Yoon JH, Han JK, Choi BI (2013) Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis. Invest Radiol 48(8):607–613. doi: 10.1097/RLI.0b013e318289ff8f
Noren B, Forsgren MF, Dahlqvist Leinhard O, et al. (2013) Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Eur Radiol 23(1):174–181. doi: 10.1007/s00330-012-2583-2
Besa C, Bane O, Jajamovich G, Marchione J, Taouli B (2015) 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Magn Reson Imaging 33(9):1075–1082. doi: 10.1016/j.mri.2015.06.013
Nassif A, Jia J, Keiser M, et al. (2012) Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Radiology 264(3):741–750. doi: 10.1148/radiol.12112061
Feier D, Balassy C, Bastati N, et al. (2016) The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis—a multiparametric approach. Eur Radiol 26(2):539–546. doi: 10.1007/s00330-015-3830-0
Sheng RF, Wang HQ, Yang L, et al. (2017) Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance. Dig Liver Dis . doi: 10.1016/j.dld.2017.02.006
Yang L, Ding Y, Rao S, et al. (2017) Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid-enhanced MRI: comparison with aspartate aminotransferase-to-platelet ratio index and FIB-4. J Magn Reson Imaging 45(4):1186–1194. doi: 10.1002/jmri.25440
Hagiwara M, Rusinek H, Lee VS, et al. (2008) Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging—initial experience. Radiology 246(3):926–934. doi: 10.1148/radiol.2463070077
Chen BB, Hsu CY, Yu CW, et al. (2012) Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol 22(1):171–180. doi: 10.1007/s00330-011-2249-5
Xie S, Sun Y, Wang L, et al. (2015) Assessment of liver function and liver fibrosis with dynamic Gd-EOB-DTPA-enhanced MRI. Acad Radiol 22(4):460–466. doi: 10.1016/j.acra.2014.11.006
Sourbron S, Sommer WH, Reiser MF, Zech CJ (2012) Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 263(3):874–883. doi: 10.1148/radiol.12110337
Zhang H, Yang Q, Yu T, et al. (2017) Comparison of T2, T1rho, and diffusion metrics in assessment of liver fibrosis in rats. J Magn Reson Imaging 45(3):741–750. doi: 10.1002/jmri.25424
Cassinotto C, Feldis M, Vergniol J, et al. (2015) MR relaxometry in chronic liver diseases: comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 84(8):1459–1465. doi: 10.1016/j.ejrad.2015.05.019
Guimaraes AR, Siqueira L, Uppal R, et al. (2016) T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg 6(2):103–114. doi: 10.21037/qims.2016.03.02
Bonekamp D, Bonekamp S, Geiger B, Kamel IR (2012) An elevated arterial enhancement fraction is associated with clinical and imaging indices of liver fibrosis and cirrhosis. J Comput Assist Tomogr 36(6):681–689. doi: 10.1097/RCT.0b013e3182702ee3
Ronot M, Asselah T, Paradis V, et al. (2010) Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology 256(1):135–142. doi: 10.1148/radiol.10091295
Van Beers BE, Leconte I, Materne R, et al. (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. Am J Roentgenol 176(3):667–673. doi: 10.2214/ajr.176.3.1760667
Richter S, Mucke I, Menger MD, Vollmar B (2000) Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 279(2):G454–G462
Gulberg V, Haag K, Rossle M, Gerbes AL (2002) Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 35(3):630–634. doi: 10.1053/jhep.2002.31722
Varenika V, Fu Y, Maher JJ, et al. (2013) Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. Radiology 266(1):151–158. doi: 10.1148/radiol.12112452
Zissen MH, Wang ZJ, Yee J, et al. (2013) Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. Am J Roentgenol 201(6):1204–1210. doi: 10.2214/AJR.12.10039
Wells ML, Moynagh MR, Carter RE, et al. (2017) Correlation of hepatic fractional extracellular space using gadolinium enhanced MRI with liver stiffness using magnetic resonance elastography. Abdom Radiol (NY) 42(1):191–198. doi: 10.1007/s00261-016-0867-8
Yoon JH, Lee JM, Klotz E, et al. (2015) Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading. Invest Radiol 50(4):290–296. doi: 10.1097/rli.0000000000000123
Bandula S, Punwani S, Rosenberg WM, et al. (2015) Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling. Radiology 275(1):136–143. doi: 10.1148/radiol.14141435
Guo SL, Su LN, Zhai YN, et al. (2017) The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis. Clin Radiol 72(3):242–246. doi: 10.1016/j.crad.2016.10.003
Silva AC, Morse BG, Hara AK, et al. (2011) Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics 31(4):1031–1046. doi: 10.1148/rg.314105159
Lamb P, Sahani DV, Fuentes-Orrego JM, et al. (2015) Stratification of patients with liver fibrosis using dual-energy CT. IEEE Trans Med Imaging 34(3):807–815. doi: 10.1109/TMI.2014.2353044
Lv P, Lin X, Gao J, Chen K (2012) Spectral CT: preliminary studies in the liver cirrhosis. Korean J Radiol 13(4):434–442. doi: 10.3348/kjr.2012.13.4.434
Zhao LQ, He W, Yan B, Wang HY, Wang J (2013) The evaluation of haemodynamics in cirrhotic patients with spectral CT. Br J Radiol 86(1028):20130228. doi: 10.1259/bjr.20130228
Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39(2):187–210. doi: 10.1016/j.ultrasmedbio.2012.09.002
Ridolfi F, Abbattista T, Marini F, et al. (2007) Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liver Dis 39(10):929–935. doi: 10.1016/j.dld.2007.06.006
Maruyama H, Matsutani S, Okugawa H, et al. (2006) Microbubble disappearance-time is the appropriate timing for liver-specific imaging after injection of Levovist. Ultrasound Med Biol 32(12):1809–1815
Li N, Ding H, Fan P, et al. (2010) Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. Ultrasound Med Biol 36(7):1066–1075. doi: 10.1016/j.ultrasmedbio.2010.04.012
Lim AK, Taylor-Robinson SD, Patel N, et al. (2005) Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 54(1):128–133. doi: 10.1136/gut.2003.030965
Tang A, Kim TK, Heathcote J, et al. (2011) Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis? Ultrasound Med Biol 37(12):1963–1969. doi: 10.1016/j.ultrasmedbio.2011.09.010
Barry B, Buch K, Soto JA, et al. (2014) Quantifying liver fibrosis through the application of texture analysis to diffusion weighted imaging. Magn Reson Imaging 32(1):84–90. doi: 10.1016/j.mri.2013.04.006
Vicas C, Lupsor M, Socaciu M, Nedevschi S, Badea R (2012) Influence of expert-dependent variability over the performance of noninvasive fibrosis assessment in patients with chronic hepatitis C by means of texture analysis. Comput Math Methods Med 2012:346713. doi: 10.1155/2012/346713
Yamada H, Ebara M, Yamaguchi T, et al. (2006) A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 cases. J Hepatol 44(1):68–75. doi: 10.1016/j.jhep.2005.08.009
Jirak D, Dezortova M, Taimr P, Hajek M (2002) Texture analysis of human liver. J Magn Reson Imaging 15(1):68–74
House MJ, Bangma SJ, Thomas M, et al. (2015) Texture-based classification of liver fibrosis using MRI. J Magn Reson Imaging 41(2):322–328. doi: 10.1002/jmri.24536
Yu H, Buch K, Li B, et al. (2015) Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI. J Magn Reson Imaging 42(5):1259–1265. doi: 10.1002/jmri.24898
Bahl G, Cruite I, Wolfson T, et al. (2012) Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images. J Magn Reson Imaging 36(5):1154–1161. doi: 10.1002/jmri.23759
Yokoo T, Wolfson T, Iwaisako K, et al. (2015) Evaluation of liver fibrosis using texture analysis on combined-contrast-enhanced magnetic resonance images at 3.0 T. BioMed Res Int 2015:387653. doi: 10.1155/2015/387653
Wu Z, Matsui O, Kitao A, et al. (2015) Hepatitis C related chronic liver cirrhosis: feasibility of texture analysis of MR images for classification of fibrosis stage and necroinflammatory activity grade. PLoS ONE 10(3):e0118297. doi: 10.1371/journal.pone.0118297
Kayaaltı Ö, Aksebzeci BH, Karahan İÖ, et al. (2014) Liver fibrosis staging using CT image texture analysis and soft computing. Appl Soft Comput 25:399–413
Daginawala N, Li B, Buch K, et al. (2016) Using texture analyses of contrast enhanced CT to assess hepatic fibrosis. Eur J Radiol 85(3):511–517. doi: 10.1016/j.ejrad.2015.12.009
Zhang X, Gao X, Liu BJ, et al. (2015) Effective staging of fibrosis by the selected texture features of liver: which one is better, CT or MR imaging? Comput Med Imaging Graph 46(Pt 2):227–236. doi: 10.1016/j.compmedimag.2015.09.003
Farrar CT, DePeralta DK, Day H, et al. (2015) 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol 63(3):689–696. doi: 10.1016/j.jhep.2015.04.029
Fuchs BC, Wang H, Yang Y, et al. (2013) Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol 59(5):992–998. doi: 10.1016/j.jhep.2013.06.026
Zhu B, Wei L, Rotile N, et al. (2017) Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model. Hepatology 65(3):1015–1025. doi: 10.1002/hep.28930
Li F, Yan H, Wang J, et al. (2016) Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin alphavbeta3 expression with an MRI modality in mice. Biomaterials 102:162–174. doi: 10.1016/j.biomaterials.2016.06.026
Hatori A, Yui J, Xie L, et al. (2015) Utility of translocator protein (18 kDa) as a molecular imaging biomarker to monitor the progression of liver fibrosis. Sci Rep 5:17327. doi: 10.1038/srep17327